Commonwealth Equity Services
PRVB

Commonwealth Equity Services’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Commonwealth Equity Services’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,964
Closed -$200K – 3895
2022
Q4 		$200K Buy
18,964
+1,966
+12% +$15.9K ﹤0.01% 3238
2022
Q3 		$76K Buy
16,998
+1,469
+9% +$6.69K ﹤0.01% 3426
2022
Q2 		$62K Buy
15,529
+358
+2% +$1.7K ﹤0.01% 3455
2022
Q1 		$111K Sell
15,171
-14
-0.1% -$84 ﹤0.01% 3460
2021
Q4 		$85K Sell
15,185
-3,600
-19% -$22.9K ﹤0.01% 3488
2021
Q3 		$120K Buy
18,785
+189
+1% +$1.22K ﹤0.01% 3386
2021
Q2 		$156K Buy
18,596
+669
+4% +$5.4K ﹤0.01% 3327
2021
Q1 		$188K Buy
17,927
+5,227
+41% +$73.6K ﹤0.01% 3150
2020
Q4 		$215K Buy
+12,700
New +$190K ﹤0.01% 2860

Other funds holding PRVB

SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Commonwealth Equity Services's PRVB Position: Q1 2023 in Review

Commonwealth Equity Services sold out of Provention Bio, Inc. Common Stock (PRVB) in Q1 2023, closing a stake of 18,964 shares — an estimated $200K sold.

Commonwealth Equity Services first reported a position in PRVB in Q4 2020 and held it in 9 quarters. The position peaked at $215K in Q4 2020. 182 funds tracked by Wall St. Rank hold PRVB as of Q1 2023.

  • Commonwealth Equity Services reported no remaining Provention Bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 18,964 Provention Bio, Inc. Common Stock shares in Q1 2023, an estimated $200K.
  • Commonwealth Equity Services first reported a position in Provention Bio, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • Commonwealth Equity Services's Provention Bio, Inc. Common Stock position peaked at $215K in Q4 2020.
  • 182 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q1 2023.

Based on Commonwealth Equity Services's 13F filing for Q1 2023, filed 11 May 2023.